等待开盘 11-26 09:30:00 美东时间
0.000
0.00%
ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (NASDAQ:STAI), a developer of advanced AI-powered security screening and imaging systems, today announced a strategic partnership with unival group, a
11-25 21:07
THOUSAND OAKS, Calif., Nov. 24, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2025 Global Healthcare Conference at 1:45 p.m. ET on December 3, 2025. Peter Griffith, executi...
11-25 05:10
SILVER SPRING, Md., Nov. 14, 2025 /PRNewswire/ -- Urban One, Inc. (NASDAQ: UONEK and UONE) (the "Company") today announced that it has commenced an offer to exchange (the "Exchange Offer") a...
11-15 05:05
ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (NASDAQ:STAI), a developer of advanced AI-powered security screening and imaging systems, today announced its participation as an exhibiting company at the
11-12 21:13
FORT LAUDERDALE, Fla., Nov. 6, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets un...
11-06 21:55
Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating relapsed/refractory Acute Myeloid
11-03 22:13
ENGLEWOOD, Colo., Oct. 28, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announced that it will be participating in The ThinkEquity Confere...
10-28 21:00
Transaction will create the largest public XRP treasury company SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- Evernorth Holdings Inc., a newly formed Nevada corporation ("Evernorth") that wil...
10-20 20:00
FORT LAUDERDALE, Fla., Oct. 20, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets u...
10-20 20:00
Karyopharm secures $100 million financing, extends cash runway into 2026, projects $42 million–$44 million Q3 revenue, and advances Phase 3 selinexor trial.
10-09 01:31